Table 1.
Patient and biopsy characteristics.
| Biopsy events (n = 60) | |
|---|---|
| Age (SD) | 65.0 (8.3) |
| Gender (%) | |
| Male | 51 (85.0) |
| Female | 9 (15.0) |
| Race/ethnicity (%) | |
| White | 42 (70.0) |
| Black/African American | 13 (21.7) |
| Hispanic/Latino | 3 (3.3) |
| Asian | 2 (5.0) |
| Etiology of HCC (%) | |
| HCV/alcohol | 20 (33.3) |
| HCV | 14 (23.3) |
| Alcohol | 8 (13.3) |
| NAFLD | 6 (10.0) |
| HBV | 2 (3.3) |
| Other | 4 (6.7) |
| Unknown | 6 (10.0) |
| Underlying cirrhosis (%) | 53 (88.3) |
| MELD score (IQR) | 8 (7–10) |
| Childs-Pugh score (%) | |
| A | 49 (81.7) |
| B | 11 (18.3) |
| C | 0 |
| BCLC stage (%) | |
| A | 11 (18.3) |
| B | 26 (43.3) |
| C | 23 (38.3) |
| AFP (ng/mL, IQR) | 14 (6–216) |
| Size of lesion (cm, IQR) | 4.2 (2.7–8.5) |
| Location of lesion | |
| Right lobe (%) | 42 (70.0) |
| Posterior/superior (%) | 16 (29.6) |
| Spans multiple segments (%) | 20 (33.9) |
| Distance of lesion from capsule (cm, IQR) | 3.5 (1.5–5.5) |
| Number of core biopsies (IQR) | 8 (7–10) |
| Gelfoam used (%) | 42 (70.0) |
| Imaging guidance (%) | |
| US only | 53 (88.3) |
| CT only | 6 (10.0) |
| US and cone beam CT | 1 (1.7) |